Abstract
Radiation-induced fibrosis (RIF) in the breast, skin, and head and neck sites can result in pain, poor cosmesis, and functional limitations. In addition, RIF in the lung, kidney, and bowel, can result in functional loss that can be extremely morbid or life threatening. Studies with pentoxifylline (PTX) have demonstrated the ability of PTX to prevent or improve chronic RIF. Endogenous tocopherol (vitamin E) protects cell membranes against lipid peroxidation. The majority of clinical studies involving PTX and/or vitamin E have investigated their potential role in reversing late radiation changes while only a few studies have focused on their possible role in prevention of delayed radiation effects. The extensive clinical trial experience from 1989 to the present suggests that PTX with or without vitamin E is effective at both preventing and reversing some manifestations of RIF. Mechanisms may include reversal of local hypoxia, inhibition of fibroblast proliferation, and reduction of oxidative stress via multiple pathways. The change in perception of RIF as fixed and irreversible to the realization that it represents a dynamic and continuous process invites us to continue to explore the mechanisms involved and to develop appropriate treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Delanian S, Lefaix JL (2007) Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol 17:99–107
Cerutti PA, Trump BF (1991) Inflammation and oxidative stress in carcinogenesis. Cancer Cells 3:1–7
Finkel T (1998) Oxygen radicals and signaling. Curr Opin Cell Biol 10:248–253
Mikkelsen RB, Wardman P (2003) Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 22:5734–5754
Riley PA (1994) Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 65:27–33
Pena LA, Fuks Z, Kolesnick R (1997) Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 53:615–621
Pena LA, Fuks Z, Kolesnick RN (2000) Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res 60:321–327
Barcellos-Hoff MH, Park C, Wright EG (2005) Radiation and the microenvironment – tumorigenesis and therapy. Nat Rev Cancer 5:867–875
Denham JW, Hauer-Jensen M (2002) The radiotherapeutic injury–a complex ‘wound’. Radiother Oncol 63:129–145
Robbins ME, Zhao W (2004) Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol 80:251–259
Clemens MR, Ladner C, Schmidt H, Ehninger G, Einsele H, Buhler E, Waller HD, Gey KF (1989) Decreased essential antioxidants and increased lipid hydroperoxides following high-dose radiochemotherapy. Free Radic Res Commun 7:227–232
Robbins ME, Zhao W, Davis CS, Toyokuni S, Bonsib SM (2002) Radiation-induced kidney injury: a role for chronic oxidative stress? Micron 33:133–141
Jack CI, Cottier B, Jackson MJ, Cassapi L, Fraser WD, Hind CR (1996) Indicators of free radical activity in patients developing radiation pneumonitis. Int J Radiat Oncol Biol Phys 34:149–154
Tofilon PJ, Fike JR (2000) The radioresponse of the central nervous system: a dynamic process. Radiat Res 153:357–370
Haroon ZA, Raleigh JA, Greenberg CS, Dewhirst MW (2000) Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann Surg 231:137–147
Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845
Poli G, Parola M (1997) Oxidative damage and fibrogenesis. Free Radic Biol Med 22:287–305
Ward A, Clissold SP (1987) Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34:50–97
Magnusson M, Gunnarsson M, Berntorp E, Bjorkman S, Hoglund P (2008) Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans. Eur J Pharmacol 581:290–295
Stefanovich V (1973) Effect of 3,7-dimethyl-1-(5-oxo-hexyl)xanthine and 1-hexyl-3,7-Âdimethyl xanthine on cyclic AMP phosphodiesterase of the human umbilical cord vessels. Res Commun Chem Pathol Pharmacol 5:655–662
Berman B, Duncan MR (1990) Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin. Br J Dermatol 123:339–346
Fang CC, Yen CJ, Chen YM, Shyu RS, Tsai TJ, Lee PH, Hsieh BS (2000) Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis: effects on TGF-beta. Kidney Int 57:2626–2633
Hung KY, Huang JW, Chen CT, Lee PH, Tsai TJ (2003) Pentoxifylline modulates intracellular signalling of TGF-beta in cultured human peritoneal mesothelial cells: implications for prevention of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 18:670–676
Lin SL, Chen RH, Chen YM, Chiang WC, Lai CF, Wu KD, Tsai TJ (2005) Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. J Am Soc Nephrol 16:2702–2713
Rajendran R, Rani V, Shaikh S (2006) Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian J Dent Res 17:190–198
Seigneur M, Dufourcq P, Belloc F, Lenoble M, Renard M, Boisseau MR (1995) Influence of pentoxifylline on membrane thrombomodulin levels in endothelial cells submitted to hypoxic conditions. J Cardiovasc Pharmacol 25(Suppl 2):S85–87
Neuner P, Klosner G, Schauer E, Pourmojib M, Macheiner W, Grunwald C, Knobler R, Schwarz A, Luger TA, Schwarz T (1994) Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology 83:262–267
Rube CE, Wilfert F, Uthe D, Schmid KW, Knoop R, Willich N, Schuck A, Rube C (2002) Modulation of radiation-induced tumour necrosis factor alpha (TNF-alpha) expression in the lung tissue by pentoxifylline. Radiother Oncol 64:177–187
Boerma M, Roberto KA, Hauer-Jensen M (2008) Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. Int J Radiat Oncol Biol Phys 72:170–177
Lefaix JL, Delanian S, Vozenin MC, Leplat JJ, Tricaud Y, Martin M (1999) Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: an experimental study. Int J Radiat Oncol Biol Phys 43:839–847
Packer L, Weber SU, Rimbach G (2001) Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J Nutr 131:369S–373S
Empey LR, Papp JD, Jewell LD, Fedorak RN (1992) Mucosal protective effects of vitamin E and misoprostol during acute radiation-induced enteritis in rats. Dig Dis Sci 37:205–214
Bese NS, Munzuroglu F, Uslu B, Arbak S, Yesiladali G, Sut N, Altug T, Ober A (2007) Vitamin E protects against the development of radiation-induced pulmonary fibrosis in rats. Clin Oncol (R Coll Radiol) 19:260–264
Baillet F (1997) Alpha-tocopherol treatment of radiofibrosis post-brachytherapy for breast cancer. Radiother Oncol 43:S3
Delanian S, Porcher R, Balla-Mekias S, Lefaix JL (2003) Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 21:2545–2550
Ferreira PR, Fleck JF, Diehl A, Barletta D, Braga-Filho A, Barletta A, Ilha L (2004) Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial. Head Neck 26:313–321
Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338–1347
Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142:37–46
Berry D, Wathen JK, Newell M (2009) Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality. Clin Trials 6:28–41
Dion MW, Hussey DH, Doornbos JF, Vigliotti AP, Wen BC, Anderson B (1990) Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis. Int J Radiat Oncol Biol Phys 19:401–407
Dion MW, Hussey DH, Osborne JW (1989) The effect of pentoxifylline on early and late radiation injury following fractionated irradiation in C3H mice. Int J Radiat Oncol Biol Phys 17:101–107
Withers HR, Peters LJ, Kolenik LJ (1980) The pathobiology of late effects of irradiation. In: Meyn RE, Withers HR (eds) Radiation biology in cancer research. Raven, New York
Fajardo LF, Stewart JR (1971) Capillary injury preceding radiation-induced myocardial fibrosis. Radiology 101:429–433
Reinhold HS, Buisman GH (1975) Repair of radiation damage to capillary endothelium. Br J Radiol 48:727–731
Delanian S, Balla-Mekias S, Lefaix JL (1999) Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 17:3283–3290
Delanian S, Porcher R, Rudant J, Lefaix JL (2005) Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 23:8570–8579
Delanian S, Lefaix JL (2002) Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate. Br J Radiol 75:467–469
Delanian S, Lefaix JL, Maisonobe T, Salachas F, Pradat PF (2008) Significant clinical improvement in radiation-induced lumbosacral polyradiculopathy by a treatment combining pentoxifylline, tocopherol, and clodronate (Pentoclo). J Neurol Sci 275:164–166
Ledee-Bataille N, Olivennes F, Lefaix JL, Chaouat G, Frydman R, Delanian S (2002) Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Hum Reprod 17:1249–1253
Letur-Konirsch H, Guis F, Delanian S (2002) Uterine restoration by radiation sequelae regression with combined pentoxifylline-tocopherol: a phase II study. Fertil Steril 77:1219–1226
Okunieff P, Augustine E, Hicks JE, Cornelison TL, Altemus RM, Naydich BG, Ding I, Huser AK, Abraham EH, Smith JJ, Coleman N, Gerber LH (2004) Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol 22:2207–2213
Haddad P, Kalaghchi B, Amouzegar-Hashemi F (2005) Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: a phase II clinical trial. Radiother Oncol 77:324–326
Hille A, Christiansen H, Pradier O, Hermann RM, Siekmeyer B, Weiss E, Hilgers R, Hess CF, Schmidberger H (2005) Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 181:606–614
Gothard L, Cornes P, Earl J, Hall E, MacLaren J, Mortimer P, Peacock J, Peckitt C, Woods M, Yarnold J (2004) Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. Radiother Oncol 73:133–139
Gothard L, Cornes P, Brooker S, Earl J, Glees J, Hall E, Peckitt C, Tait D, Yarnold J (2005) Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy. Radiother Oncol 75:334–341
Ozturk B, Egehan I, Atavci S, Kitapci M (2004) Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial. Int J Radiat Oncol Biol Phys 58:213–219
(1995) LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 31:1049–1091
CTC (1998) Cancer therapy evaluation program. In: NCI (ed) Common toxicity criteria version 2. DCDT, DHHS, Bethesda
Aygenc E, Celikkanat S, Kaymakci M, Aksaray F, Ozdem C (2004) Prophylactic effect of pentoxifylline on radiotherapy complications: a clinical study. Otolaryngol Head Neck Surg 130:351–356
Magnusson M, Hoglund P, Johansson K, Jonsson C, Killander F, Malmstrom P, Weddig A, Kjellen E (2009) Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). Eur J Cancer 45:2488–2495
Scott J, Huskisson EC (1976) Graphic representation of pain. Pain 2:175–184
Jacobson G, Smith BJ, Bodeker K (2008) A randomized trial of pentoxifylline and vitamin E versus standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter (TCM). J Clin Oncol 26
Kwon HC, Kim SK, Chung WK, Cho MJ, Kim JS, Moon SR, Park WY, Ahn SJ, Oh YK, Yun HG, Na BS (2000) Effect of pentoxifylline on radiation response of non-small cell lung cancer: a phase III randomized multicenter trial. Radiother Oncol 56:175–179
Theron T, Binder A, Verheye-Dua F, Bohm L (2000) The role of G2-block abrogation, DNA double-strand break repair and apoptosis in the radiosensitization of melanoma and squamous cell carcinoma cell lines by pentoxifylline. Int J Radiat Biol 76:1197–1208
Vernimmen F, Verheye-Dua F, du Toit H, Bohm L (1994) Effect of pentoxifylline on radiation damage and tumor growth. Strahlenther Onkol 170:595–601
Friedman N (1988) The effects of irradiation on breast cancer and the breast. CA Cancer J Clin 38:368–371
Leith JT, Michelson S (1990) Tumor radiocurability: relationship to intrinsic tumor heterogeneity and to the tumor bed effect. Invasion Metastasis 10:329–351
Hartsell WF, Scott CB, Dundas GS, Mohiuddin M, Meredith RF, Rubin P, Weigensberg IJ (2007) Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91–03. Am J Clin Oncol 30:368–376
Zhao L, Sheldon K, Chen M, Yin MS, Hayman JA, Kalemkerian GP, Arenberg D, Lyons SE, Curtis JL, Davis M, Cease KB, Brenner D, Anscher MS, Lawrence TS, Kong FM (2008) The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer 59:232–239
Fernet M, Hall J (2008) Predictive markers for normal tissue reactions: fantasy or reality? Cancer Radiother 12:614–618
Canney PA, Dean S (1990) Transforming growth factor beta: a promotor of late connective tissue injury following radiotherapy? Br J Radiol 63:620–623
Martin M, Lefaix JL, Pinton P, Crechet F, Daburon F (1993) Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res 134:63–70
Rodemann HP, Binder A, Bamberg M (1995) Radiation induced fibrosis: experimental studies. In: Sauer R, Dunst J (eds) Late sequelae in oncology. Springer, Berlin
Sivan V, Vozenin-Brotons MC, Tricaud Y, Lefaix JL, Cosset JM, Dubray B, Martin MT (2002) Altered proliferation and differentiation of human epidermis in cases of skin fibrosis after radiotherapy. Int J Radiat Oncol Biol Phys 53:385–393
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jacobson, G. (2012). Pentoxifylline, Vitamin E, and Modification of Radiation-Induced Fibrosis. In: Spitz, D., Dornfeld, K., Krishnan, K., Gius, D. (eds) Oxidative Stress in Cancer Biology and Therapy. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-397-4_17
Download citation
DOI: https://doi.org/10.1007/978-1-61779-397-4_17
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-396-7
Online ISBN: 978-1-61779-397-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)